Retatrutide
Lyophilized synthetic peptide supplied in a sealed sterile vial. Characterized by HPLC and mass spectrometry. For in-vitro laboratory research use only. Not for human or veterinary use.
Sold strictly as a lyophilized analytical reference standard for in-vitro laboratory research by qualified professionals. Not for use in any living organism. Not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, diagnostic, or health claims are made. No dosing or administration guidance is provided.
Research Overview
The 20 mg size of the triple-receptor metabolic peptide, for studies that need more material.
Retatrutide acts on the GLP-1, GIP, and glucagon receptors — three pathways tied closely to metabolism. Researchers have studied appetite-related signaling, blood sugar control, and fat and energy metabolism. The 20 mg vial is a popular choice where a larger amount of reference material is required.
- Appetite and satiety signaling
- Glucose handling in research models
- Fat and energy metabolism markers
- Larger-volume or longer study designs
For laboratory reference information only. Not for human or animal use. No preparation or administration guidance is provided.
Certificate of Analysis
No matching report is currently published for this exact product and strength. Contact support with the lot printed on your vial to request available documentation.
- Compound
- Retatrutide
- CAS
- 2381089-83-2
- Method
- See the exact report methods
- Purity
- >99.0% (HPLC)
- Grade
- Research
- Net Content
- 20 mg / vial